nodes	percent_of_prediction	percent_of_DWPC	metapath
Prochlorperazine—CYP3A4—Thiotepa—sarcoma	0.117	0.404	CbGbCtD
Prochlorperazine—CYP3A4—Mitoxantrone—sarcoma	0.0505	0.174	CbGbCtD
Prochlorperazine—CYP3A4—Vincristine—sarcoma	0.0347	0.12	CbGbCtD
Prochlorperazine—CYP2D6—Doxorubicin—sarcoma	0.0342	0.118	CbGbCtD
Prochlorperazine—CYP3A4—Etoposide—sarcoma	0.0318	0.11	CbGbCtD
Prochlorperazine—CYP3A4—Doxorubicin—sarcoma	0.0217	0.0748	CbGbCtD
Prochlorperazine—Pigmentation disorder—Doxorubicin—sarcoma	0.00689	0.00971	CcSEcCtD
Prochlorperazine—Cyanosis—Etoposide—sarcoma	0.00627	0.00883	CcSEcCtD
Prochlorperazine—Dermatitis contact—Thiotepa—sarcoma	0.0061	0.0086	CcSEcCtD
Prochlorperazine—Amenorrhoea—Mitoxantrone—sarcoma	0.00607	0.00855	CcSEcCtD
Prochlorperazine—Laryngospasm—Etoposide—sarcoma	0.00594	0.00837	CcSEcCtD
Prochlorperazine—Aplastic anaemia—Dactinomycin—sarcoma	0.00575	0.00811	CcSEcCtD
Prochlorperazine—Gait disturbance—Vincristine—sarcoma	0.00561	0.00791	CcSEcCtD
Prochlorperazine—Apnoea—Etoposide—sarcoma	0.00523	0.00737	CcSEcCtD
Prochlorperazine—Coma—Vincristine—sarcoma	0.005	0.00705	CcSEcCtD
Prochlorperazine—Embolism venous—Epirubicin—sarcoma	0.00493	0.00694	CcSEcCtD
Prochlorperazine—Embolism venous—Doxorubicin—sarcoma	0.00456	0.00642	CcSEcCtD
Prochlorperazine—Cardiac arrest—Thiotepa—sarcoma	0.00426	0.00601	CcSEcCtD
Prochlorperazine—Urinary retention—Thiotepa—sarcoma	0.00426	0.00601	CcSEcCtD
Prochlorperazine—Eruption—Epirubicin—sarcoma	0.00404	0.0057	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Mitoxantrone—sarcoma	0.004	0.00564	CcSEcCtD
Prochlorperazine—Dysphagia—Dactinomycin—sarcoma	0.00384	0.00542	CcSEcCtD
Prochlorperazine—Urinary retention—Vincristine—sarcoma	0.00378	0.00533	CcSEcCtD
Prochlorperazine—Cardiac arrest—Vincristine—sarcoma	0.00378	0.00533	CcSEcCtD
Prochlorperazine—Eruption—Doxorubicin—sarcoma	0.00374	0.00527	CcSEcCtD
Prochlorperazine—Pancytopenia—Thiotepa—sarcoma	0.00368	0.00518	CcSEcCtD
Prochlorperazine—Pancytopenia—Dactinomycin—sarcoma	0.00365	0.00515	CcSEcCtD
Prochlorperazine—Weight increased—Thiotepa—sarcoma	0.00353	0.00497	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Thiotepa—sarcoma	0.00349	0.00492	CcSEcCtD
Prochlorperazine—Jaundice—Thiotepa—sarcoma	0.00337	0.00474	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Etoposide—sarcoma	0.00333	0.00469	CcSEcCtD
Prochlorperazine—Pancytopenia—Vincristine—sarcoma	0.00326	0.0046	CcSEcCtD
Prochlorperazine—Agranulocytosis—Thiotepa—sarcoma	0.00322	0.00454	CcSEcCtD
Prochlorperazine—Agranulocytosis—Dactinomycin—sarcoma	0.0032	0.00451	CcSEcCtD
Prochlorperazine—Pancytopenia—Mitoxantrone—sarcoma	0.00318	0.00448	CcSEcCtD
Prochlorperazine—Erectile dysfunction—Vincristine—sarcoma	0.00316	0.00446	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Vincristine—sarcoma	0.00314	0.00442	CcSEcCtD
Prochlorperazine—Erectile dysfunction—Mitoxantrone—sarcoma	0.00308	0.00434	CcSEcCtD
Prochlorperazine—Glycosuria—Epirubicin—sarcoma	0.00307	0.00432	CcSEcCtD
Prochlorperazine—Cardiac arrest—Etoposide—sarcoma	0.00306	0.00431	CcSEcCtD
Prochlorperazine—Weight increased—Mitoxantrone—sarcoma	0.00304	0.00429	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Mitoxantrone—sarcoma	0.00302	0.00425	CcSEcCtD
Prochlorperazine—Drowsiness—Mitoxantrone—sarcoma	0.00298	0.0042	CcSEcCtD
Prochlorperazine—Blood disorder—Epirubicin—sarcoma	0.00298	0.0042	CcSEcCtD
Prochlorperazine—Liver injury—Epirubicin—sarcoma	0.00295	0.00416	CcSEcCtD
Prochlorperazine—Erythema multiforme—Dactinomycin—sarcoma	0.00291	0.0041	CcSEcCtD
Prochlorperazine—Jaundice—Mitoxantrone—sarcoma	0.00291	0.0041	CcSEcCtD
Prochlorperazine—Glycosuria—Doxorubicin—sarcoma	0.00284	0.004	CcSEcCtD
Prochlorperazine—Amenorrhoea—Epirubicin—sarcoma	0.00283	0.00399	CcSEcCtD
Prochlorperazine—Jaundice cholestatic—Epirubicin—sarcoma	0.00283	0.00399	CcSEcCtD
Prochlorperazine—Agranulocytosis—Mitoxantrone—sarcoma	0.00278	0.00392	CcSEcCtD
Prochlorperazine—Dysphagia—Etoposide—sarcoma	0.00278	0.00392	CcSEcCtD
Prochlorperazine—Arrhythmia—Thiotepa—sarcoma	0.00277	0.0039	CcSEcCtD
Prochlorperazine—Blood disorder—Doxorubicin—sarcoma	0.00275	0.00388	CcSEcCtD
Prochlorperazine—Liver injury—Doxorubicin—sarcoma	0.00273	0.00385	CcSEcCtD
Prochlorperazine—Erythema—Thiotepa—sarcoma	0.0027	0.0038	CcSEcCtD
Prochlorperazine—Erythema—Dactinomycin—sarcoma	0.00268	0.00378	CcSEcCtD
Prochlorperazine—Dyskinesia—Epirubicin—sarcoma	0.00265	0.00373	CcSEcCtD
Prochlorperazine—Pancytopenia—Etoposide—sarcoma	0.00264	0.00372	CcSEcCtD
Prochlorperazine—Nervousness—Thiotepa—sarcoma	0.00262	0.00369	CcSEcCtD
Prochlorperazine—Amenorrhoea—Doxorubicin—sarcoma	0.00262	0.00369	CcSEcCtD
Prochlorperazine—Jaundice cholestatic—Doxorubicin—sarcoma	0.00262	0.00369	CcSEcCtD
Prochlorperazine—Gait disturbance—Epirubicin—sarcoma	0.00255	0.00359	CcSEcCtD
Prochlorperazine—Vision blurred—Thiotepa—sarcoma	0.00254	0.00359	CcSEcCtD
Prochlorperazine—Pulmonary embolism—Epirubicin—sarcoma	0.00249	0.0035	CcSEcCtD
Prochlorperazine—Hepatocellular injury—Epirubicin—sarcoma	0.00249	0.0035	CcSEcCtD
Prochlorperazine—Agitation—Thiotepa—sarcoma	0.00248	0.0035	CcSEcCtD
Prochlorperazine—Dermatitis contact—Epirubicin—sarcoma	0.00246	0.00346	CcSEcCtD
Prochlorperazine—Dyskinesia—Doxorubicin—sarcoma	0.00245	0.00345	CcSEcCtD
Prochlorperazine—Jaundice—Etoposide—sarcoma	0.00242	0.00341	CcSEcCtD
Prochlorperazine—Leukopenia—Thiotepa—sarcoma	0.00242	0.00341	CcSEcCtD
Prochlorperazine—Leukopenia—Dactinomycin—sarcoma	0.0024	0.00338	CcSEcCtD
Prochlorperazine—Arrhythmia—Mitoxantrone—sarcoma	0.00239	0.00337	CcSEcCtD
Prochlorperazine—Gait disturbance—Doxorubicin—sarcoma	0.00236	0.00332	CcSEcCtD
Prochlorperazine—Cough—Thiotepa—sarcoma	0.00236	0.00332	CcSEcCtD
Prochlorperazine—Convulsion—Thiotepa—sarcoma	0.00234	0.0033	CcSEcCtD
Prochlorperazine—Aplastic anaemia—Epirubicin—sarcoma	0.00233	0.00329	CcSEcCtD
Prochlorperazine—Erythema—Mitoxantrone—sarcoma	0.00233	0.00329	CcSEcCtD
Prochlorperazine—Agranulocytosis—Etoposide—sarcoma	0.00232	0.00326	CcSEcCtD
Prochlorperazine—Pulmonary embolism—Doxorubicin—sarcoma	0.0023	0.00324	CcSEcCtD
Prochlorperazine—Hepatocellular injury—Doxorubicin—sarcoma	0.0023	0.00324	CcSEcCtD
Prochlorperazine—Dermatitis contact—Doxorubicin—sarcoma	0.00227	0.0032	CcSEcCtD
Prochlorperazine—Coma—Epirubicin—sarcoma	0.00227	0.0032	CcSEcCtD
Prochlorperazine—Agitation—Vincristine—sarcoma	0.0022	0.0031	CcSEcCtD
Prochlorperazine—Vision blurred—Mitoxantrone—sarcoma	0.0022	0.0031	CcSEcCtD
Prochlorperazine—Infection—Thiotepa—sarcoma	0.00219	0.00308	CcSEcCtD
Prochlorperazine—Oedema—Dactinomycin—sarcoma	0.00219	0.00308	CcSEcCtD
Prochlorperazine—Infection—Dactinomycin—sarcoma	0.00217	0.00306	CcSEcCtD
Prochlorperazine—Aplastic anaemia—Doxorubicin—sarcoma	0.00216	0.00304	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Thiotepa—sarcoma	0.00216	0.00304	CcSEcCtD
Prochlorperazine—Leukopenia—Vincristine—sarcoma	0.00214	0.00302	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Dactinomycin—sarcoma	0.00214	0.00302	CcSEcCtD
Prochlorperazine—Skin disorder—Thiotepa—sarcoma	0.00214	0.00302	CcSEcCtD
Prochlorperazine—Erythema multiforme—Etoposide—sarcoma	0.00211	0.00297	CcSEcCtD
Prochlorperazine—Coma—Doxorubicin—sarcoma	0.0021	0.00296	CcSEcCtD
Prochlorperazine—Leukopenia—Mitoxantrone—sarcoma	0.00209	0.00294	CcSEcCtD
Prochlorperazine—Convulsion—Vincristine—sarcoma	0.00207	0.00292	CcSEcCtD
Prochlorperazine—Photosensitivity—Epirubicin—sarcoma	0.00206	0.0029	CcSEcCtD
Prochlorperazine—Cough—Mitoxantrone—sarcoma	0.00203	0.00287	CcSEcCtD
Prochlorperazine—Convulsion—Mitoxantrone—sarcoma	0.00202	0.00285	CcSEcCtD
Prochlorperazine—Eczema—Epirubicin—sarcoma	0.00201	0.00283	CcSEcCtD
Prochlorperazine—Somnolence—Thiotepa—sarcoma	0.00196	0.00276	CcSEcCtD
Prochlorperazine—Oedema—Vincristine—sarcoma	0.00195	0.00275	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Vincristine—sarcoma	0.00195	0.00275	CcSEcCtD
Prochlorperazine—Infection—Vincristine—sarcoma	0.00194	0.00274	CcSEcCtD
Prochlorperazine—Increased appetite—Epirubicin—sarcoma	0.00192	0.00271	CcSEcCtD
Prochlorperazine—Dermatitis exfoliative—Epirubicin—sarcoma	0.00191	0.0027	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Vincristine—sarcoma	0.00191	0.0027	CcSEcCtD
Prochlorperazine—Oedema—Mitoxantrone—sarcoma	0.0019	0.00268	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Mitoxantrone—sarcoma	0.0019	0.00268	CcSEcCtD
Prochlorperazine—Photosensitivity—Doxorubicin—sarcoma	0.0019	0.00268	CcSEcCtD
Prochlorperazine—Infection—Mitoxantrone—sarcoma	0.00189	0.00266	CcSEcCtD
Prochlorperazine—Constipation—Thiotepa—sarcoma	0.00188	0.00265	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Epirubicin—sarcoma	0.00186	0.00263	CcSEcCtD
Prochlorperazine—Muscle spasms—Etoposide—sarcoma	0.00186	0.00263	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Mitoxantrone—sarcoma	0.00186	0.00263	CcSEcCtD
Prochlorperazine—Eczema—Doxorubicin—sarcoma	0.00186	0.00262	CcSEcCtD
Prochlorperazine—Hypoglycaemia—Epirubicin—sarcoma	0.00185	0.00261	CcSEcCtD
Prochlorperazine—Skin disorder—Mitoxantrone—sarcoma	0.00185	0.0026	CcSEcCtD
Prochlorperazine—Hypotension—Vincristine—sarcoma	0.00183	0.00257	CcSEcCtD
Prochlorperazine—Hypotension—Mitoxantrone—sarcoma	0.00178	0.00251	CcSEcCtD
Prochlorperazine—Increased appetite—Doxorubicin—sarcoma	0.00178	0.0025	CcSEcCtD
Prochlorperazine—Dermatitis exfoliative—Doxorubicin—sarcoma	0.00177	0.00249	CcSEcCtD
Prochlorperazine—Insomnia—Vincristine—sarcoma	0.00177	0.00249	CcSEcCtD
Prochlorperazine—Urticaria—Thiotepa—sarcoma	0.00175	0.00247	CcSEcCtD
Prochlorperazine—Body temperature increased—Thiotepa—sarcoma	0.00174	0.00245	CcSEcCtD
Prochlorperazine—Leukopenia—Etoposide—sarcoma	0.00174	0.00245	CcSEcCtD
Prochlorperazine—Body temperature increased—Dactinomycin—sarcoma	0.00173	0.00244	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Doxorubicin—sarcoma	0.00173	0.00243	CcSEcCtD
Prochlorperazine—Cardiac arrest—Epirubicin—sarcoma	0.00172	0.00242	CcSEcCtD
Prochlorperazine—Hypoglycaemia—Doxorubicin—sarcoma	0.00171	0.00241	CcSEcCtD
Prochlorperazine—Dyspnoea—Mitoxantrone—sarcoma	0.0017	0.00239	CcSEcCtD
Prochlorperazine—Cough—Etoposide—sarcoma	0.00169	0.00238	CcSEcCtD
Prochlorperazine—Somnolence—Mitoxantrone—sarcoma	0.00169	0.00238	CcSEcCtD
Prochlorperazine—Convulsion—Etoposide—sarcoma	0.00168	0.00237	CcSEcCtD
Prochlorperazine—Constipation—Vincristine—sarcoma	0.00167	0.00235	CcSEcCtD
Prochlorperazine—Constipation—Mitoxantrone—sarcoma	0.00163	0.00229	CcSEcCtD
Prochlorperazine—Hypersensitivity—Thiotepa—sarcoma	0.00162	0.00229	CcSEcCtD
Prochlorperazine—Hypersensitivity—Dactinomycin—sarcoma	0.00161	0.00227	CcSEcCtD
Prochlorperazine—Cardiac arrest—Doxorubicin—sarcoma	0.00159	0.00224	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Etoposide—sarcoma	0.00158	0.00223	CcSEcCtD
Prochlorperazine—Infection—Etoposide—sarcoma	0.00157	0.00222	CcSEcCtD
Prochlorperazine—Influenza—Epirubicin—sarcoma	0.00156	0.0022	CcSEcCtD
Prochlorperazine—Dysphagia—Epirubicin—sarcoma	0.00156	0.0022	CcSEcCtD
Prochlorperazine—Asthma—Epirubicin—sarcoma	0.00156	0.0022	CcSEcCtD
Prochlorperazine—Pruritus—Thiotepa—sarcoma	0.00156	0.0022	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Etoposide—sarcoma	0.00155	0.00218	CcSEcCtD
Prochlorperazine—Eosinophilia—Epirubicin—sarcoma	0.00154	0.00218	CcSEcCtD
Prochlorperazine—Body temperature increased—Vincristine—sarcoma	0.00154	0.00218	CcSEcCtD
Prochlorperazine—Skin disorder—Etoposide—sarcoma	0.00154	0.00217	CcSEcCtD
Prochlorperazine—Urticaria—Mitoxantrone—sarcoma	0.00151	0.00213	CcSEcCtD
Prochlorperazine—Body temperature increased—Mitoxantrone—sarcoma	0.0015	0.00212	CcSEcCtD
Prochlorperazine—Pancytopenia—Epirubicin—sarcoma	0.00148	0.00209	CcSEcCtD
Prochlorperazine—Hypotension—Etoposide—sarcoma	0.00148	0.00208	CcSEcCtD
Prochlorperazine—Dizziness—Thiotepa—sarcoma	0.00146	0.00205	CcSEcCtD
Prochlorperazine—Dysphagia—Doxorubicin—sarcoma	0.00144	0.00203	CcSEcCtD
Prochlorperazine—Influenza—Doxorubicin—sarcoma	0.00144	0.00203	CcSEcCtD
Prochlorperazine—Asthma—Doxorubicin—sarcoma	0.00144	0.00203	CcSEcCtD
Prochlorperazine—Hypersensitivity—Vincristine—sarcoma	0.00144	0.00203	CcSEcCtD
Prochlorperazine—Eosinophilia—Doxorubicin—sarcoma	0.00143	0.00201	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Epirubicin—sarcoma	0.00142	0.00201	CcSEcCtD
Prochlorperazine—Weight increased—Epirubicin—sarcoma	0.00142	0.002	CcSEcCtD
Prochlorperazine—Dyspnoea—Etoposide—sarcoma	0.00141	0.00199	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Epirubicin—sarcoma	0.00141	0.00198	CcSEcCtD
Prochlorperazine—Somnolence—Etoposide—sarcoma	0.00141	0.00198	CcSEcCtD
Prochlorperazine—Hypersensitivity—Mitoxantrone—sarcoma	0.0014	0.00198	CcSEcCtD
Prochlorperazine—Drowsiness—Epirubicin—sarcoma	0.00139	0.00196	CcSEcCtD
Prochlorperazine—Rash—Thiotepa—sarcoma	0.00139	0.00196	CcSEcCtD
Prochlorperazine—Dermatitis—Thiotepa—sarcoma	0.00139	0.00196	CcSEcCtD
Prochlorperazine—Headache—Thiotepa—sarcoma	0.00138	0.00194	CcSEcCtD
Prochlorperazine—Rash—Dactinomycin—sarcoma	0.00138	0.00194	CcSEcCtD
Prochlorperazine—Pancytopenia—Doxorubicin—sarcoma	0.00137	0.00193	CcSEcCtD
Prochlorperazine—Jaundice—Epirubicin—sarcoma	0.00136	0.00191	CcSEcCtD
Prochlorperazine—Constipation—Etoposide—sarcoma	0.00135	0.00191	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Doxorubicin—sarcoma	0.00132	0.00186	CcSEcCtD
Prochlorperazine—Weight increased—Doxorubicin—sarcoma	0.00131	0.00185	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Doxorubicin—sarcoma	0.0013	0.00183	CcSEcCtD
Prochlorperazine—Agranulocytosis—Epirubicin—sarcoma	0.0013	0.00183	CcSEcCtD
Prochlorperazine—Dizziness—Vincristine—sarcoma	0.00129	0.00182	CcSEcCtD
Prochlorperazine—Drowsiness—Doxorubicin—sarcoma	0.00129	0.00181	CcSEcCtD
Prochlorperazine—Urticaria—Etoposide—sarcoma	0.00126	0.00177	CcSEcCtD
Prochlorperazine—Jaundice—Doxorubicin—sarcoma	0.00125	0.00177	CcSEcCtD
Prochlorperazine—Body temperature increased—Etoposide—sarcoma	0.00125	0.00176	CcSEcCtD
Prochlorperazine—Rash—Vincristine—sarcoma	0.00123	0.00174	CcSEcCtD
Prochlorperazine—Dermatitis—Vincristine—sarcoma	0.00123	0.00173	CcSEcCtD
Prochlorperazine—Oedema peripheral—Epirubicin—sarcoma	0.00123	0.00173	CcSEcCtD
Prochlorperazine—Headache—Vincristine—sarcoma	0.00122	0.00172	CcSEcCtD
Prochlorperazine—Agranulocytosis—Doxorubicin—sarcoma	0.0012	0.00169	CcSEcCtD
Prochlorperazine—Rash—Mitoxantrone—sarcoma	0.0012	0.00169	CcSEcCtD
Prochlorperazine—Dermatitis—Mitoxantrone—sarcoma	0.0012	0.00169	CcSEcCtD
Prochlorperazine—Headache—Mitoxantrone—sarcoma	0.00119	0.00168	CcSEcCtD
Prochlorperazine—Erythema multiforme—Epirubicin—sarcoma	0.00118	0.00166	CcSEcCtD
Prochlorperazine—Hypersensitivity—Etoposide—sarcoma	0.00117	0.00164	CcSEcCtD
Prochlorperazine—Oedema peripheral—Doxorubicin—sarcoma	0.00114	0.0016	CcSEcCtD
Prochlorperazine—Pruritus—Etoposide—sarcoma	0.00112	0.00158	CcSEcCtD
Prochlorperazine—Arrhythmia—Epirubicin—sarcoma	0.00112	0.00157	CcSEcCtD
Prochlorperazine—Erythema multiforme—Doxorubicin—sarcoma	0.00109	0.00154	CcSEcCtD
Prochlorperazine—Erythema—Epirubicin—sarcoma	0.00109	0.00153	CcSEcCtD
Prochlorperazine—Nervousness—Epirubicin—sarcoma	0.00106	0.00149	CcSEcCtD
Prochlorperazine—Dizziness—Etoposide—sarcoma	0.00105	0.00147	CcSEcCtD
Prochlorperazine—Muscle spasms—Epirubicin—sarcoma	0.00104	0.00147	CcSEcCtD
Prochlorperazine—Arrhythmia—Doxorubicin—sarcoma	0.00103	0.00145	CcSEcCtD
Prochlorperazine—Vision blurred—Epirubicin—sarcoma	0.00102	0.00144	CcSEcCtD
Prochlorperazine—Erythema—Doxorubicin—sarcoma	0.00101	0.00142	CcSEcCtD
Prochlorperazine—Agitation—Epirubicin—sarcoma	0.000999	0.00141	CcSEcCtD
Prochlorperazine—Rash—Etoposide—sarcoma	0.000998	0.00141	CcSEcCtD
Prochlorperazine—Dermatitis—Etoposide—sarcoma	0.000997	0.0014	CcSEcCtD
Prochlorperazine—Headache—Etoposide—sarcoma	0.000991	0.0014	CcSEcCtD
Prochlorperazine—Nervousness—Doxorubicin—sarcoma	0.000977	0.00138	CcSEcCtD
Prochlorperazine—Leukopenia—Epirubicin—sarcoma	0.000973	0.00137	CcSEcCtD
Prochlorperazine—Muscle spasms—Doxorubicin—sarcoma	0.000967	0.00136	CcSEcCtD
Prochlorperazine—Cough—Epirubicin—sarcoma	0.000948	0.00134	CcSEcCtD
Prochlorperazine—Vision blurred—Doxorubicin—sarcoma	0.000948	0.00134	CcSEcCtD
Prochlorperazine—Convulsion—Epirubicin—sarcoma	0.000942	0.00133	CcSEcCtD
Prochlorperazine—Agitation—Doxorubicin—sarcoma	0.000924	0.0013	CcSEcCtD
Prochlorperazine—Dry mouth—Epirubicin—sarcoma	0.000905	0.00128	CcSEcCtD
Prochlorperazine—Leukopenia—Doxorubicin—sarcoma	0.0009	0.00127	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Epirubicin—sarcoma	0.000887	0.00125	CcSEcCtD
Prochlorperazine—Oedema—Epirubicin—sarcoma	0.000887	0.00125	CcSEcCtD
Prochlorperazine—Infection—Epirubicin—sarcoma	0.000881	0.00124	CcSEcCtD
Prochlorperazine—Cough—Doxorubicin—sarcoma	0.000878	0.00124	CcSEcCtD
Prochlorperazine—Convulsion—Doxorubicin—sarcoma	0.000871	0.00123	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Epirubicin—sarcoma	0.000869	0.00122	CcSEcCtD
Prochlorperazine—Skin disorder—Epirubicin—sarcoma	0.000862	0.00121	CcSEcCtD
Prochlorperazine—Dry mouth—Doxorubicin—sarcoma	0.000837	0.00118	CcSEcCtD
Prochlorperazine—Hypotension—Epirubicin—sarcoma	0.000829	0.00117	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Doxorubicin—sarcoma	0.000821	0.00116	CcSEcCtD
Prochlorperazine—Oedema—Doxorubicin—sarcoma	0.000821	0.00116	CcSEcCtD
Prochlorperazine—Infection—Doxorubicin—sarcoma	0.000815	0.00115	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Doxorubicin—sarcoma	0.000804	0.00113	CcSEcCtD
Prochlorperazine—Insomnia—Epirubicin—sarcoma	0.000802	0.00113	CcSEcCtD
Prochlorperazine—Skin disorder—Doxorubicin—sarcoma	0.000797	0.00112	CcSEcCtD
Prochlorperazine—Dyspnoea—Epirubicin—sarcoma	0.000791	0.00111	CcSEcCtD
Prochlorperazine—Somnolence—Epirubicin—sarcoma	0.000789	0.00111	CcSEcCtD
Prochlorperazine—Hypotension—Doxorubicin—sarcoma	0.000767	0.00108	CcSEcCtD
Prochlorperazine—Constipation—Epirubicin—sarcoma	0.000759	0.00107	CcSEcCtD
Prochlorperazine—Insomnia—Doxorubicin—sarcoma	0.000742	0.00105	CcSEcCtD
Prochlorperazine—Dyspnoea—Doxorubicin—sarcoma	0.000732	0.00103	CcSEcCtD
Prochlorperazine—Somnolence—Doxorubicin—sarcoma	0.00073	0.00103	CcSEcCtD
Prochlorperazine—Urticaria—Epirubicin—sarcoma	0.000705	0.000993	CcSEcCtD
Prochlorperazine—Constipation—Doxorubicin—sarcoma	0.000702	0.000989	CcSEcCtD
Prochlorperazine—Body temperature increased—Epirubicin—sarcoma	0.000701	0.000988	CcSEcCtD
Prochlorperazine—Hypersensitivity—Epirubicin—sarcoma	0.000654	0.000921	CcSEcCtD
Prochlorperazine—Urticaria—Doxorubicin—sarcoma	0.000652	0.000919	CcSEcCtD
Prochlorperazine—Body temperature increased—Doxorubicin—sarcoma	0.000649	0.000914	CcSEcCtD
Prochlorperazine—Pruritus—Epirubicin—sarcoma	0.000628	0.000884	CcSEcCtD
Prochlorperazine—Hypersensitivity—Doxorubicin—sarcoma	0.000605	0.000852	CcSEcCtD
Prochlorperazine—Dizziness—Epirubicin—sarcoma	0.000587	0.000827	CcSEcCtD
Prochlorperazine—Pruritus—Doxorubicin—sarcoma	0.000581	0.000818	CcSEcCtD
Prochlorperazine—Rash—Epirubicin—sarcoma	0.000559	0.000788	CcSEcCtD
Prochlorperazine—Dermatitis—Epirubicin—sarcoma	0.000559	0.000787	CcSEcCtD
Prochlorperazine—Headache—Epirubicin—sarcoma	0.000556	0.000783	CcSEcCtD
Prochlorperazine—Dizziness—Doxorubicin—sarcoma	0.000543	0.000765	CcSEcCtD
Prochlorperazine—Rash—Doxorubicin—sarcoma	0.000517	0.000729	CcSEcCtD
Prochlorperazine—Dermatitis—Doxorubicin—sarcoma	0.000517	0.000729	CcSEcCtD
Prochlorperazine—Headache—Doxorubicin—sarcoma	0.000514	0.000725	CcSEcCtD
